ClinicalTrials.govpublic full text
Reduction or Discontinuation of CNI's With Conversion to Everolimus-Based Immunosuppresion
kidney diseases, everolimus, renal transplant, tacrolimus, certican, chronic allograft nephropathy, renal transplant patients, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 840521
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.